Cantargia AB announced the appointment of Sven Andreasson as chairman of the board. Sven Andréasson has extensive experience in both pharmaceutical and biotech companies. From March 2012 to November 2013 he was CEO of Isconova AB in Uppsala, initiating the acquisition of the company by Novavax Inc. where he now holds a position as advisor and Director in Novavax AB.

In addition, he has held a vast number of senior management positions within Pharmacia in Sweden, Germany, Belgium and France.